Insights into age-related macular degeneration

Age-related macular degeneration (AMD) is a complex and prevalent ocular condition with significant implications for vision and quality of life in the aging population. This chapter provides a comprehensive exploration of AMD, encompassing its multifactorial pathophysiology, epidemiologic trends, and associated risk factors. A detailed examination of the distinct features and symptoms characterizing neovascular and dry AMD enhances our understanding of the clinical spectrum. Special emphasis is placed on geographic atrophy (GA), an advanced stage of AMD, highlighting its significant impact on visual outcomes. Apart from examining the present diagnostic methods and criteria for AMD, this chapter assesses current therapeutic approaches, with a specific emphasis on antivascular endothelial growth factor (anti-VEGF) treatments. Additionally, the discussion extends to emerging therapies and potential avenues for future research in AMD. Preventative strategies and lifestyle modifications that may influence disease progressions are also reviewed. By consolidating current knowledge, clinical insights, and future prospects, this chapter aims to serve as a valuable resource for clinicians, researchers, and students engaged in the study and management of age-related macular degeneration.